Directory

>

Ken Prentice

avatar

Ken Prentice

Senior Vice President, Head of Process Development and Manufacturing | Shape Therapeutics Inc.

Seattle, Washington, United States

View contact details (it's free)

Ken Prentice

Summary

Ken Prentice is a seasoned leader in biotherapeutic drug development with over 20 years of experience. He has a proven track record of building innovative teams and advancing cutting-edge techniques in the biopharmaceutical space, particularly in CAR-T and rAAV gene therapies. Ken's expertise spans a wide array of technical disciplines including assay development, protein chemistry, and regulatory compliance. His leadership roles at Shape Therapeutics have allowed him to drive significant advancements in process and product development. He is known for his strategic planning capabilities and his ability to navigate complex regulatory landscapes. Ken is passionate about leveraging technology to enhance therapeutic outcomes and improve patient care. His academic background in Chemistry and Oceanography from the University of Washington complements his extensive industry experience. Ken's work is characterized by a blend of rigorous scientific inquiry and practical application, making him a valuable asset in the realm of biopharmaceuticals.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Ken Prentice

Work Experience

company logo

Senior Vice President, Head of Process Development and Manufacturing at

Shape Therapeutics Inc.

July 2024 - Present

company logo

Vice President, Head of Process and Product Development at

Shape Therapeutics Inc.

August 2021 - July 2024

company logo

Director, Head of Process and Product Development at

Shape Therapeutics Inc.

October 2020 - August 2021

company logo

Head of Process and Product Development at

Shape Therapeutics Inc.

March 2019 - August 2021

company logo

Senior Scientist at

Bristol Myers Squibb

March 2017 - March 2019

company logo

Scientist at

Bristol Myers Squibb

May 2015 - March 2017

company logo

Senior Associate Scientist, Analytical Sciences at

Amgen, Inc.

March 2013 - May 2015

company logo

Associate Scientist, Analytical and Formulation Sciences at

Amgen, Inc.

April 2008 - March 2013

company logo

Sr. Associate, Quality Control at

Amgen, Inc.

August 2002 - April 2008

company logo

Forensic Scientist 2 at

State of Washington

July 2000 - September 2002

company logo

Student Research Assistant at

University of Washington, LLC

October 1998 - June 2002

Logos provided by Logo.dev

Ken Prentice

Education

University of Washington, Bs

January 1995 - January 2000

Frequently Asked Questions about Ken Prentice

What is Ken Prentice email address?

Ken Prentice's primary email address is ***@shapetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Ken Prentice work for?

Ken Prentice is a Senior Vice President, Head of Process Development and Manufacturing at Shape Therapeutics Inc., a company specializing in Commercial physical research.

Where Ken Prentice graduated from?

Ken Prentice holds a degree in Chemistry And Oceanography from University of Washington.

How can I directly contact Ken Prentice?

To contact Ken Prentice directly, you can use the email address ***@shapetx.com. Complete contact information is available upon registration with Muraena.

Who is Ken Prentice?

Ken Prentice is a seasoned leader in biotherapeutic drug development with over 20 years of experience. He has a proven track record of building innovative teams and advancing cutting-edge techniques in the biopharmaceutical space, particularly in CAR-T and rAAV gene therapies. Ken's expertise spans a wide array of technical disciplines including assay development, protein chemistry, and regulatory compliance. His leadership roles at Shape Therapeutics have allowed him to drive significant advancements in process and product development. He is known for his strategic planning capabilities and his ability to navigate complex regulatory landscapes. Ken is passionate about leveraging technology to enhance therapeutic outcomes and improve patient care. His academic background in Chemistry and Oceanography from the University of Washington complements his extensive industry experience. Ken's work is characterized by a blend of rigorous scientific inquiry and practical application, making him a valuable asset in the realm of biopharmaceuticals.

Ken`s contact details

mail

***@shapetx.com

************@junotherapeutics.com

Colleagues

avatar
Patrick Bigot

Chief Business Officer

avatar
Ron Hause

Senior Vice President, Head of Analytics and Informatics

avatar
Lisa Taylor Ash

General Counsel and Head of Operations

avatar
David Huss

Interim Chief Executive Officer

avatar
Gayathri Rajan

Senior Vice President of Product

avatar
Jamie Siemering Phr Shrm-Cp

Vice President, People Operations

avatar
John Suliman

Co-Founder

avatar
Adrian Briggs

Chief Technology Officer

View Contact details (it's free)
Request Profile Removal